CP

Chris Price

Board Director, NCCN Foundation at The National Comprehensive Cancer Network (NCCN)

Chris Price is a seasoned professional in the healthcare investment sector, currently serving as the Founder and Managing Partner of Epilog Partners since October 2020, where the focus is on investing in tech-enabled healthcare services to enhance clinical and financial outcomes. Price holds positions as an Investor and Board Member at CareMetx, LLC, and as a Board Director for the NCCN Foundation. Previously, Price has been instrumental in various roles including Chairman of the Board at WithMe Health and ReCept Pharmacy, Partner at Oak HC/FT, and Senior Vice President at ADVI Health and EnvisionRxOptions, contributing to significant advances in health technology and services. Price's educational background includes a BSFA in Economics with Financial Applications from Southern Methodist University.

Links